Jabil Inc. (JBL)
| Previous Close | 58.03 |
| Open | 57.60 |
| Bid | 56.15 x 1400 |
| Ask | 56.27 x 900 |
| Day's Range | 56.15 - 57.50 |
| 52 Week Range | 52.43 - 72.11 |
| Volume | |
| Avg. Volume | 1,081,498 |
| Market Cap | 7.942B |
| Beta (5Y Monthly) | 1.38 |
| PE Ratio (TTM) | 10.38 |
| EPS (TTM) | 5.42 |
| Earnings Date | Jun 15, 2022 - Jun 20, 2022 |
| Forward Dividend & Yield | 0.32 (0.56%) |
| Ex-Dividend Date | May 13, 2022 |
| 1y Target Est | 82.17 |
- Business Wire
Jabil Helps Cardo Systems Set New Standard in Helmet Communication Systems
ST. PETERSBURG, Fla., May 24, 2022--Jabil (NYSE: JBL) today announced an innovative manufacturing collaboration with Cardo Systems, a pioneer in wireless group communications and entertainment systems for motorcycle riders. Cardo’s path to market leadership has been fueled by Jabil’s world-class manufacturing capabilities, acoustics experience, global supply chain expertise and dedicated Workcell model, which enables Cardo to ship more than one million devices yearly to customers in more than 10
- Zacks
Jabil (JBL) Dips More Than Broader Markets: What You Should Know
In the latest trading session, Jabil (JBL) closed at $57.57, marking a -1.4% move from the previous day.
- Business Wire
Jabil Healthcare Announces the Launch of the Qfinity™ Autoinjector Platform, a Reusable Drug Delivery Device with Broad Applicability
ST. PETERSBURG, Fla., May 18, 2022--Jabil Healthcare, a division of Jabil Inc. (NYSE: JBL), announces the launch of the Qfinity™ autoinjector platform, a simple, reusable and modular solution for subcutaneous (SC) drug self-administration, at a lower cost than market alternatives — supporting the emerging prioritization of sustainable drug delivery within the pharmaceutical industry.
